Skip to main content
Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.200
+0.670 (18.98%)
At close: Nov 20, 2024, 4:00 PM
4.830
+0.630 (15.00%)
Pre-market: Nov 21, 2024, 7:39 AM EST

Exagen Revenue

Exagen had revenue of $12.51M in the quarter ending September 30, 2024, a decrease of -6.78%. This brings the company's revenue in the last twelve months to $55.75M, up 8.00% year-over-year. In the year 2023, Exagen had annual revenue of $52.55M with 15.33% growth.

Revenue (ttm)
$55.75M
Revenue Growth
+8.00%
P/S Ratio
1.36
Revenue / Employee
$311,458
Employees
179
Market Cap
73.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202352.55M6.99M15.33%
Dec 31, 202245.56M-2.74M-5.66%
Dec 31, 202148.30M6.32M15.07%
Dec 31, 202041.98M1.59M3.93%
Dec 31, 201940.39M7.95M24.50%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Theratechnologies 84.32M
Owlet 78.61M
Prenetics Global 22.66M
DBV Technologies 12.52M
Nutriband 1.80M
Revenue Rankings

XGN News

More News